PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Ts66Yah, a mouse model of Down syndrome with improved construct and face validity.Disease models & mechanisms · 2022
   Article
2. Influence of allelic differences in Down syndrome.Progress in brain research · 2020
   Review
3. Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome.Physiological reports · 2015
   Article
4. Involvement of Potassium and Cation Channels in Hippocampal Abnormalities of Embryonic Ts65Dn and Tc1 Trisomic Mice.EBioMedicine · 2015
   Article
5. Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation.The Journal of biological chemistry · 2015
   Article
6. Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
   Article
7. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.Circulation. Cardiovascular genetics · 2012
   Article
8. Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.Mammalian genome : official journal of the International Mammalian Genome Society · 2011
   Article
9. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome.Mammalian genome : official journal of the International Mammalian Genome Society · 2011
   Article
10. Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome.Cancer research · 2011
    Article
11. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.Developmental neuroscience · 2011
    Article
12. Increased male reproductive success in Ts65Dn "Down syndrome" mice.Mammalian genome : official journal of the International Mammalian Genome Society · 2010
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as